ES2573524T3 - Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden - Google Patents

Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden Download PDF

Info

Publication number
ES2573524T3
ES2573524T3 ES12719767.1T ES12719767T ES2573524T3 ES 2573524 T3 ES2573524 T3 ES 2573524T3 ES 12719767 T ES12719767 T ES 12719767T ES 2573524 T3 ES2573524 T3 ES 2573524T3
Authority
ES
Spain
Prior art keywords
redness
active ingredient
cosmetic compositions
new anti
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12719767.1T
Other languages
English (en)
Inventor
Philippe Msika
Caroline Baudouin
Franck Menu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Application granted granted Critical
Publication of ES2573524T3 publication Critical patent/ES2573524T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición que comprende arabinogalactano para su utilización en la prevención y/o el tratamiento del enrojecimiento de la piel en una persona susceptible de formar o que tiene enrojecimiento.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19

Claims (1)

  1. imagen1
ES12719767.1T 2011-05-13 2012-05-11 Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden Active ES2573524T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1154181 2011-05-13
FR1154181A FR2975004B1 (fr) 2011-05-13 2011-05-13 Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
PCT/EP2012/058798 WO2012156319A1 (fr) 2011-05-13 2012-05-11 Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant

Publications (1)

Publication Number Publication Date
ES2573524T3 true ES2573524T3 (es) 2016-06-08

Family

ID=46046254

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12719767.1T Active ES2573524T3 (es) 2011-05-13 2012-05-11 Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden

Country Status (5)

Country Link
US (1) US8877261B2 (es)
EP (1) EP2706976B1 (es)
ES (1) ES2573524T3 (es)
FR (1) FR2975004B1 (es)
WO (1) WO2012156319A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
FR3022139B1 (fr) * 2014-06-12 2016-07-22 Laboratoires Dermatologiques D'uriage Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
LT3157534T (lt) * 2014-06-19 2022-09-12 Attillaps Holdings Acetilcholinesterazės inhibitoriai, skirti dermatologinių būklių gydymui
WO2016090150A1 (en) 2014-12-03 2016-06-09 Mary Kay Inc. Cosmetic composition and methods of use thereof
FR3037790B1 (fr) * 2015-06-23 2019-06-07 Laboratoires De Biologie Vegetale Yves Rocher Composition cosmetique comprenant une vitamine, un lipoaminoacide et un polysaccharide
US10206868B2 (en) 2015-12-30 2019-02-19 Mary Kay Inc. Topical compositions
US11847040B2 (en) 2016-03-16 2023-12-19 Asg Technologies Group, Inc. Systems and methods for detecting data alteration from source to target
US11057500B2 (en) * 2017-11-20 2021-07-06 Asg Technologies Group, Inc. Publication of applications using server-side virtual screen change capture
US11611633B2 (en) 2017-12-29 2023-03-21 Asg Technologies Group, Inc. Systems and methods for platform-independent application publishing to a front-end interface
US11055067B2 (en) 2019-10-18 2021-07-06 Asg Technologies Group, Inc. Unified digital automation platform
US11886397B2 (en) 2019-10-18 2024-01-30 Asg Technologies Group, Inc. Multi-faceted trust system
US11755760B2 (en) 2019-10-18 2023-09-12 Asg Technologies Group, Inc. Systems and methods for secure policies-based information governance
US11941137B2 (en) 2019-10-18 2024-03-26 Asg Technologies Group, Inc. Use of multi-faceted trust scores for decision making, action triggering, and data analysis and interpretation
US12299146B2 (en) 2020-10-13 2025-05-13 Rocket Software Technologies, Inc. Secure sharing of documents created via content management repository
EP4229534A4 (en) 2020-10-13 2024-08-28 ASG Technologies Group, Inc. DBA ASG Technologies GEOLOCATION-BASED POLICY RULES
WO2022140467A1 (en) * 2020-12-21 2022-06-30 Samson Pharma, Llc Topical compositions and methods of treating skin diseases and conditions with such compositions

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958525A (es) 1950-03-13
FR955343A (es) 1950-01-14
FR958529A (es) 1950-03-13
FR955344A (es) 1941-03-29 1950-01-14
FR1061051A (fr) 1951-07-31 1954-04-08 Heinrich Lanz Ag Procédé pour la fabrication de moissonneuses, notamment de moissonneuses-lieuses de divers types
FR1061047A (fr) 1952-07-28 1954-04-08 Aluminium Francais Radiateur à ailettes
FR1061055A (fr) 1952-07-28 1954-04-08 Perfectionnement aux amortisseurs hydrauliques télescopiques de suspensions
US5756098A (en) 1995-12-12 1998-05-26 The University Of Montana Methods for the extraction of phytochemicals from fibrous plants in the absence of solvent
FR2762512B1 (fr) 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
FR2798667B1 (fr) 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
FR2798591B1 (fr) 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
FR2803749B1 (fr) 2000-01-18 2006-09-22 Pharmascience Lab Utilisation d'au moins un ester gras pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha-reductase, en pharmacie notamment en dermatologie, en cosmetique et en tant qu'additif alimentaire
FR2811984B1 (fr) 2000-07-19 2004-02-06 Pharmascience Lab Procede de preparation d'un ester de corps gras et son utilisation dans les domaines pharmaceutique, cosmetique ou alimentaire
FR2822821B1 (fr) 2001-04-03 2004-05-07 Pharmascience Lab Extrait de coques de graines de lupin contenant du lupeol, en particulier extrait riche en lupeol et son procede de preparation
FR2836378A1 (fr) 2002-02-28 2003-08-29 Cognis France Sa Utilisation de preparations a activite d'interleukine pour l'amelioration du mecanisme de reparation de l'adn dans des cellules humaines
US6994875B2 (en) 2002-07-29 2006-02-07 Laboratoires Expanscience Process for obtaining a furan lipid-rich unsaponifiable material from avocado
ES2295624T3 (es) 2002-07-30 2008-04-16 Laboratoires Expanscience Procedimiento de obtencion de un extracto de hojas de aguacate rico en lipidos furanicos.
FR2847471B1 (fr) 2002-11-25 2006-12-29 Expanscience Lab Composition comprenant au moins un derive d'acide carbamique ,son utilisation cosmetique et comme medicament
FR2847473B1 (fr) 2002-11-25 2007-06-29 Expanscience Lab Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament
FR2855050B1 (fr) * 2003-05-22 2008-07-04 Oreal Procede de traitement cosmetique des rougeurs
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
FR2856298B1 (fr) 2003-06-19 2007-08-17 Expanscience Lab Extrait de maca et composition cosmetique comprenant un tel extrait
FR2857596B1 (fr) 2003-07-18 2006-02-03 Expanscience Lab Utilisation d'une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol, a titre de principe actif, pour stimuler la synthese des proteines de stress
US7601368B2 (en) * 2004-09-01 2009-10-13 Lupin Limited Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
FR2868703B1 (fr) 2004-04-08 2008-06-13 Expanscience Sa Lab Extrait total de lupin constitue d'un extrait de sucres de lupin et d'un extrait peptidique de lupin, procede d'obtention et utilisation
FR2869543B1 (fr) 2004-04-30 2006-07-28 Expanscience Laboratoires Sa Medicament comprenant un extrait peptidique d'avocat destine au traitement et la prevention des maladies liees a une deficience du systeme immunitaire
FR2869541B1 (fr) 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
PL1600461T3 (pl) 2004-05-24 2013-05-31 Nestec Sa Arabinogalaktanowy izolat z zielonej i prażonej kawy do żywności i zastosowań w dostarczaniu, oraz sposób jego wytwarzania
FR2885301B1 (fr) * 2005-03-17 2011-03-04 Jean Noel Thorel Composition cosmetique ou dermatologique destinee a diminuer et/ou corriger les rougeurs de la peau
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
JP2009149523A (ja) 2006-03-01 2009-07-09 Ucc Ueshima Coffee Co Ltd 免疫賦活剤とその製造方法
FR2903903B1 (fr) 2006-07-18 2008-08-29 Expanscience Laboratoires Sa Utilisation d'un hydrolysat de proteines de riz en tant que principe actif pigmentant
FR2910815B1 (fr) 2006-12-28 2010-10-29 Expanscience Lab Composition comprenant un extrait de graines de quinoa
FR2938192B1 (fr) * 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
WO2010007175A2 (en) 2008-07-18 2010-01-21 Galderma Research & Development Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them
EP2116237A1 (en) 2008-08-05 2009-11-11 Polichem SA Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
US20120128597A1 (en) 2008-08-16 2012-05-24 Forschungszentrum Borstel Composition for prevention and treatment of allergic and/or inflammatory diseases
FR2948565B1 (fr) 2009-07-30 2011-10-28 Expanscience Lab Composition cosmetique pour le traitement de l'acne comprenant un extrait petidique de schizandra
FR2948566B1 (fr) 2009-07-30 2012-08-10 Expanscience Lab Extrait du fruit de schizandra sphenanthera et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant

Also Published As

Publication number Publication date
FR2975004B1 (fr) 2013-06-28
WO2012156319A1 (fr) 2012-11-22
FR2975004A1 (fr) 2012-11-16
US8877261B2 (en) 2014-11-04
HK1192152A1 (zh) 2014-08-15
EP2706976B1 (fr) 2016-03-02
EP2706976A1 (fr) 2014-03-19
US20130177662A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
ES2573524T3 (es) Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden
CL2013003577A1 (es) Uso de una composicion farmaceutica que comprende panobinostat y ruxolitinib en la prevencion y/o tratamiento de neoplasias mieloproliferativas.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
SMT201600182B (it) Ligandi sigma per l'uso nella prevenzione e/o nel trattamento del dolore post-operatorio
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
MX378726B (es) Uso de compuestos de tiazolida para la prevencion y tratamiento de enfermedades virales, cancer y enfermedades causadas por infecciones intracelulares.
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
ES2711427T8 (es) Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos
MX347858B (es) Composición antimicrobiana.
CL2013002193A1 (es) Uso de un producto que comprende macitentano o una sal del mismo en combinacion con un agente alquilante o un inhibidor mitotico para preparar un medicamento util en el tratamiento de glioma maligno.
MX354483B (es) Composición antimicrobiana.
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.
GT201200279A (es) Combinaciones de principios activos
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
MX376014B (es) Composicion para el cuidado bucal.
SG11201405778WA (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
MX349767B (es) Cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi-metil) -naftalen-2-il-metil]-amonio para su uso en el tratamiento de distrofia muscular.
AR084435A1 (es) Combinacion y composicion para el tratamiento de obesidad
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
MX2014015921A (es) Composicion antimicrobiana.